微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.08% | 205.88% | 8.9% | 37/69 | 2.26% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 1.91% | -53.86% | 402.63% | 44/69 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 0.38% | -88.69% | 153.33% | 57/69 | 3.08% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 0.15% | -93.39% | -77.94% | 56/69 | 0.67% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 0.68% | -59.04% | -83.57% | 54/69 | 1.53% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 4.14% | -33.44% | 23.21% | 44/69 | 0.11% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 3.36% | 5% | 48.02% | 51/69 | 7.26% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 2.27% | 77.34% | 36.75% | 50/69 | 4.93% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 1.66% | 348.65% | -73.31% | 51/69 | 3.21% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 6.22% | 15450% | 94.38% | 38/69 | 6.65% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 3.2% | 384.85% | 150% | 50/69 | 5.16% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 1.28% | 109.84% | 245.95% | 55/69 | 3.2% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 0.37% | -67.26% | 825% | 59/69 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 0.04% | -98.65% | -93.94% | 61/69 | 4.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 0.66% | 1750% | 8.2% | 61/69 | 7.54% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 0.61% | 334.62% | -46.02% | 63/69 | 4.68% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 1.13% | 352% | -61.95% | 54/69 | 2.7% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 2.97% | 117.25% | 7525% | 51/69 | 0.1% | *ST长药 | 7.37% | 行业排名> |
| 2020-09-30 | -0.04% | -101.54% | 84.62% | 63/69 | 6.79% | 沃华医药 | 22.84% | 行业排名> |
| 2020-06-30 | -0.26% | -116.56% | -204% | 59/69 | 3.75% | 沃华医药 | 19.47% | 行业排名> |
| 2020-03-31 | 0.25% | -76.64% | 101.45% | 57/69 | 2.14% | 沃华医药 | 12.7% | 行业排名> |
| 2019-12-31 | -17.22% | -484.38% | -762.31% | 63/69 | 5.86% | 济川药业 | 7.33% | 行业排名> |
| 2019-09-30 | 2.6% | 15.56% | 65.61% | 54/69 | 7.3% | 济川药业 | 27.43% | 行业排名> |
| 2019-06-30 | 1.57% | 9.03% | 46.73% | 55/69 | 4.72% | 济川药业 | 23.05% | 行业排名> |
| 2019-03-31 | 1.07% | 9.18% | -76.12% | 52/69 | 2.92% | 济川药业 | 15.79% | 行业排名> |
| 2018-12-31 | 4.48% | 118.15% | 99.11% | 50/69 | 7.87% | 华润三九 | 10.23% | 行业排名> |
| 2018-09-30 | 2.25% | 61.87% | 56.25% | 56/69 | 8.02% | 济川药业 | 32.79% | 行业排名> |
| 2018-06-30 | 1.44% | 42.57% | 46.94% | 56/69 | 5.03% | 济川药业 | 27.55% | 行业排名> |
| 2018-03-31 | 0.98% | 24.05% | 103.97% | 52/69 | 2.75% | 济川药业 | 17.62% | 行业排名> |
| 2017-12-31 | -24.69% | -527.9% | -1876.26% | 65/69 | 9.93% | 济川药业 | 10.07% | 行业排名> |
| 2017-09-30 | 1.39% | -35.94% | 37.62% | 60/69 | 8.39% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-06-30 | 1.01% | -40.24% | 27.85% | 60/69 | 5.24% | 济川药业 | 24.2% | 行业排名> |
| 2017-03-31 | 0.79% | -4.82% | -86.31% | 51/69 | 2.62% | *ST大药 | 15.31% | 行业排名> |
| 2016-12-31 | 5.77% | -18.85% | 165.9% | 50/69 | 10.02% | 济川药业 | 14.64% | 行业排名> |
| 2016-09-30 | 2.17% | -53.83% | 28.4% | 53/69 | 9.32% | 济川药业 | 7.64% | 行业排名> |
| 2016-06-30 | 1.69% | -49.4% | 103.61% | 53/69 | 5.04% | 维康药业 | 38.23% | 行业排名> |
| 2016-03-31 | 0.83% | -48.77% | -88.33% | 50/69 | 4.1% | 太极集团 | 58.41% | 行业排名> |
| 2015-12-31 | 7.11% | -8.02% | 51.28% | 45/69 | 11.34% | 新光药业 | 16.54% | 行业排名> |
| 2015-09-30 | 4.7% | -23.7% | 40.72% | 42/69 | 8.44% | 太极集团 | 71.6% | 行业排名> |
| 2015-06-30 | 3.34% | -14.14% | 106.17% | 42/69 | 5.48% | 维康药业 | 48.67% | 行业排名> |
| 2015-03-31 | 1.62% | -19.4% | -79.04% | 40/69 | 2.9% | 济川药业 | 21.37% | 行业排名> |